Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mutations of the MDR1 P-glycoprotein that improves its ability to confer resistance to chemotherapeutic drugs

Mutations of the MDR1 P-glycoprotein that improves its ability to confer resistance to chemotherapeutic drugs

US Patent 7309584 · Granted Dec 18, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Quinoline-based compounds and methods of inhibiting CDK8/192025
Bicyclic pyridine compositions and methods of using the same for cancer therapy2023
Quinoline-based compounds and methods of inhibiting CDK8/192021
CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreven2021
Cell-based methods for measuring activity of a protein inhibitor2020
Method for treating prostate cancer2017
CDKI pathway inhibitors and uses thereof2016
CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreven2016
CDKI pathway inhibitors and uses thereof2013
High-content screening for drugs against cancer and age-related diseases2013
Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses2009
Reagents and methods for identifying gene targets for treating cancer2007